| pubmed-article:241679 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:241679 | lifeskim:mentions | umls-concept:C0439861 | lld:lifeskim |
| pubmed-article:241679 | lifeskim:mentions | umls-concept:C0003962 | lld:lifeskim |
| pubmed-article:241679 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:241679 | lifeskim:mentions | umls-concept:C1518174 | lld:lifeskim |
| pubmed-article:241679 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
| pubmed-article:241679 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:241679 | pubmed:dateCreated | 1976-1-8 | lld:pubmed |
| pubmed-article:241679 | pubmed:abstractText | A hypoalbuminemic substance (F-3), which was obtained from Ehrlich ascites carcinoma cells, showed a marked vascular permeability-increasing action in mice. The highest increasing effect was produced 20 min after an intradermal injection of F-3. This action was inhibited by diisopropyl fluorophosphate, soybean trypsin inhibitor, and indomethacin but not by hydrocortisone or D-2-bromolysergic acid diethylamide. The inhibition of F-3 by diisopropyl fluorophosphate was observed in partial even after the excess diisopropyl fluorophosphate was removed from the diisopropyl fluorophosphate-treated F-3. The hypoalbuminemic and hypoproteinemic actions were not subjected to any inhibition by the diisopropyl fluorophosphate treatment. The decrease in albumin produced 3 hr after the injection of F-3 would be due to the leakage of albumin from blood vessels. F-3 might contain at least two components, one being a vascular permeability-increasing substance and the other a hypoalbuminemic one. | lld:pubmed |
| pubmed-article:241679 | pubmed:language | eng | lld:pubmed |
| pubmed-article:241679 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:241679 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:241679 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:241679 | pubmed:issn | 0016-450X | lld:pubmed |
| pubmed-article:241679 | pubmed:author | pubmed-author:KubotaYY | lld:pubmed |
| pubmed-article:241679 | pubmed:author | pubmed-author:UekiHH | lld:pubmed |
| pubmed-article:241679 | pubmed:author | pubmed-author:TsunemiSS | lld:pubmed |
| pubmed-article:241679 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:241679 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:241679 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:241679 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:241679 | pubmed:pagination | 237-43 | lld:pubmed |
| pubmed-article:241679 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-A... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-M... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-T... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-P... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-T... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-T... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-M... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-I... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-S... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-K... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-L... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-C... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-H... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-C... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-A... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-I... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-D... | lld:pubmed |
| pubmed-article:241679 | pubmed:meshHeading | pubmed-meshheading:241679-S... | lld:pubmed |
| pubmed-article:241679 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:241679 | pubmed:articleTitle | Vascular permeability-increasing action of hypoalbuminemic substance from Ehrlich ascites carcinoma cells. | lld:pubmed |
| pubmed-article:241679 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:241679 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:241679 | lld:pubmed |
